(Q37119305)

18 August 2017

1 reference

title

Fatty liver, insulin resistance, and dyslipidemia (English)

1 reference

18 August 2017

1 reference

1 reference

1 reference

3

Jan Borén

1 reference

18 August 2017

Marja-Riitta Taskinen

series ordinal

2

object named as

Marja-Riitta Taskinen

1 reference

18 August 2017

Martin Adiels

1

1 reference

18 August 2017

publication date

1 February 2008

1 reference

18 August 2017

published in

Current diabetes report

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

60-64

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-008-0011-4

18 August 2017

exact match

0 references

cites work

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-008-0011-4

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

12 December 2020

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

1 reference

12 December 2020

New insight into the pathophysiology of lipid abnormalities in type 2 diabetes

1 reference

12 December 2020

Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity

1 reference

12 December 2020

Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance

1 reference

12 December 2020

Dietary fat content modifies liver fat in overweight nondiabetic subjects.

1 reference

12 December 2020

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

1 reference

12 December 2020

Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease

1 reference

12 December 2020

Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects

1 reference

12 December 2020

Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders

1 reference

12 December 2020

Activation of peroxisome proliferator-activated receptor alpha increases the expression and activity of microsomal triglyceride transfer protein in the liver

1 reference

12 December 2020

Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia

1 reference

12 December 2020

Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration

1 reference

12 December 2020

Mitochondrial glycerol-3-phosphate acyltransferase-1 is essential in liver for the metabolism of excess acyl-CoAs

1 reference

12 December 2020

Thematic review series: patient-oriented research. Recent advances in liver triacylglycerol and fatty acid metabolism using stable isotope labeling techniques

1 reference

12 December 2020

Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.

1 reference

12 December 2020

Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.

1 reference

12 December 2020

Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans

1 reference

12 December 2020

Kinetic model for production and metabolism of very low density lipoprotein triglycerides. Evidence for a slow production pathway and results for normolipidemic subjects

1 reference

12 December 2020

Overproduction of large VLDL particles is driven by increased liver fat content in man.

1 reference

12 December 2020

VALIDATION OF AN INCOMPLETELY COUPLED TWO-COMPARTMENT NONRECYCLING CATENARY MODEL FOR TURNOVER OF LIVER AND PLASMA TRIGLYCERIDE IN MAN

1 reference

12 December 2020

Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis

1 reference

12 December 2020

Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects

1 reference

12 December 2020

Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver

1 reference

12 December 2020

Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors

1 reference

12 December 2020

Diabetic dyslipidaemia

1 reference

12 December 2020

Glucose and insulin function through two distinct transcription factors to stimulate expression of lipogenic enzyme genes in liver.

1 reference

12 December 2020

Measuring very low density lipoprotein-triglyceride kinetics in man in vivo: how different the various methods really are.

1 reference

12 December 2020

Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease

1 reference

12 December 2020

Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals

1 reference

12 December 2020

PPARalpha deficiency increases secretion and serum levels of apolipoprotein B-containing lipoproteins

1 reference

12 December 2020

Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus

1 reference

12 December 2020

Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance

1 reference

12 December 2020

Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity

1 reference

12 December 2020

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

1 reference

12 December 2020

Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states

1 reference

12 December 2020

A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions

1 reference

12 December 2020

Metabolic syndrome: focus on dyslipidemia

1 reference

12 December 2020

Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48.

1 reference

12 December 2020

Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance

1 reference

12 December 2020

Conversion of plasma free fatty acids into triglycerides of plasma lipoprotein fractions in man

1 reference

12 December 2020

Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance

1 reference

12 December 2020

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

12 December 2020

Endogenous cholesterol synthesis is associated with VLDL-2 apoB-100 production in healthy humans.

1 reference

12 December 2020

Lipoprotein transport in the metabolic syndrome: methodological aspects of stable isotope kinetic studies.

1 reference

12 December 2020

Molecular mediators of hepatic steatosis and liver injury

1 reference

12 December 2020

Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome

1 reference

12 December 2020

Diabetic dyslipidaemia: from basic research to clinical practice.

1 reference

12 December 2020

Cellular mechanisms of insulin resistance

1 reference

12 December 2020

10.1007/S11892-008-0011-4

Identifiers

DOI

1 reference

18 August 2017

1 reference